European Archives - Page 94 of 995 - European Medical Journal

Rise in Oropharynx Cancer Rates in Scotland Over the Past 20 Years

A new study has highlighted shifting trends in head and neck cancers in Scotland, particularly focusing on the past two decades

Preconception Prediabetes Increases Risk of Adverse Birth Outcomes

A study shows that adolescents with prediabetes have a higher risk of developing gestational diabetes and adverse birth outcomes, highlighting the need for early intervention.

AZ's Dr Sunil Verma on the next chapter in cancer care

Ever wondered what one of the world’s top oncology leaders believes to be the next big thing in cancer care? Find out in our interview AstraZeneca’s Dr Sunil Verma.

Congress Wrap: ESMO 2024

Our wrap-up video captures all the key moments, from the latest in clinical trial results to new pivotal developments presented at ESMO 2024

Whole-Food, Plant-Based Diet Improves Glycaemic Control in Type 2 Diabetes

Study finds a plant-based diet and exercise outperform standard care in managing type 2 diabetes, improving glycaemic control and reducing medication use.

ViiV Healthcare's Jean-Bernard Simeon

ViiV Healthcare’s Jean-Bernard Simeon on ending the HIV epidemic

Join JB, ViiV Healthcare Europe to explore the HIV landscape in Europe, the UNAIDS plan to end the epidemic by 2030 and more in this podcast.

Hema Now: Episode 1: Bridging Medicine, Wellness, and Community – Part 1

This week’s episode discusses the effects of COVID-19 on patients with haematological conditions, and medical education globally.

Residual Disease Dynamics and Prognosis in Multiple Myeloma

A UCSF study highlights the importance of MRD assessment and clonal diversity in predicting clinical outcomes for multiple myeloma patients

Indoor Allergens Increase Respiratory Infections in Children with Asthma

A study links indoor allergens, particularly cockroach and mouse allergens, to increased upper respiratory infections in children with asthma from disadvantaged communities.

Coin stacks

Genentech acquires Regor’s next-gen CKD inhibitor portfolio

Genentech has acquired Regor Pharmaceuticals’ next-generation CDK inhibitors for breast cancer treatment in a deal worth $850M.